As JP­Mor­gan mad­ness sub­sides, De­moc­rats will un­veil a leg­isla­tive pack­age to ad­dress drug price hikes

On the night be­fore the start of JP Mor­gan — a con­fer­ence where bio­phar­ma ex­ec­u­tives big and small waxed lyri­cal about in­no­va­tion, adorned with name badges fea­tur­ing a gold DNA cap­sule — Pres­i­dent Don­ald Trump tweet­ed his dis­plea­sure that drug­mak­ers were not hon­or­ing their promis­es to rein in prices. He wasn’t wrong. Da­ta sug­gest drug­mak­ers have re­turned to busi­ness as usu­al. And now, af­ter De­moc­rats clawed back con­trol of the House, they’re ex­pect­ed to un­veil a leg­isla­tive pack­age to­day to ad­dress what the White House has so far at­tempt­ed in vain to do: cut prices for pre­scrip­tion drugs.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Principal

Alexandria Real Estate Equities

Cambridge, MA, USA